← Back to headlines
Stifel and Jefferies Raise Price Targets for Tango Therapeutics Stock
Investment firms Stifel and Jefferies have both raised their price targets for Tango Therapeutics (TNGX) stock, signaling positive outlooks for the company.
6 Apr, 21:10 — 6 Apr, 21:10
Sources
Showing 1 of 1 sources
Related Stories
Hungary’s Paks Nuclear Plant Returns to Full Power Output Ahead of Schedule
15m ago
Jennifer Garner Reveals Career Anxiety and Financial Fears Following Divorce
24m ago
Nigerian Government and Student Union Criticize Atiku’s Push to Restore Fuel Subsidies
45m ago
Meta Agrees to $18 Billion Settlement in Child Social Media Addiction Lawsuits
51m ago